Global Cardiac Defibrillators Market Growth 2023-2029

Global Cardiac Defibrillators Market Growth 2023-2029

Defibrillation is a common treatment for life-threatening cardiac dysrhythmias, ventricular fibrillation and pulseless ventricular tachycardia. Defibrillation consists of delivering a therapeutic dose of electrical energy to the heart with a device called a defibrillator. This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia and allows normal sinus rhythm to be reestablished by the body's natural pacemaker, in the sinoatrial node of the heart. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. Some external units, known as automated external defibrillators (AEDs), automate the diagnosis of treatable rhythms, meaning that lay responders or bystanders are able to use them successfully with little or no training at all.

LPI (LP Information)' newest research report, the “Cardiac Defibrillators Industry Forecast” looks at past sales and reviews total world Cardiac Defibrillators sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiac Defibrillators sales for 2023 through 2029. With Cardiac Defibrillators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Defibrillators industry.

This Insight Report provides a comprehensive analysis of the global Cardiac Defibrillators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiac Defibrillators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiac Defibrillators market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Defibrillators and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Defibrillators.

The global Cardiac Defibrillators market size is projected to grow from US$ 11470 million in 2022 to US$ 14910 million in 2029; it is expected to grow at a CAGR of 14910 from 2023 to 2029.

North America accounted for a significant share of the overall market in 2016. This contribution can be attributed to increasing incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes, increasing awareness, and increase in training programs.

Asia Pacific was identified as the fastest growing market for defibrillators. Tremendous growth opportunities are observed in this region due to increasing awareness and accessibility of these devices. In addition, increasing prevalence of cardiovascular diseases in this region also supports growth of this segment.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Defibrillators market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Automatic External Defibrillators
Implantable Cardioverter Defibrillators
Wearable Defibrillators
Advanced Life Support (ALS) Defibrillators

Segmentation by application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott
Boston Scientific
Biotronik
Sorin Group
Philips Healthcare
Cardiac Science
Zoll Medical
HeartSine Technologies
Physio-Control
Welch Allyn(Zoll)
Schiller
PRIMEDIC
GE Healthcare
Nihon Kohden

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiac Defibrillators market?

What factors are driving Cardiac Defibrillators market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiac Defibrillators market opportunities vary by end market size?

How does Cardiac Defibrillators break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.